Earnings Ahead

ITCI - Intra-Cellular Therapies Inc.

62.7 0.09 0.14

Intra-Cellular Therapies Inc.

Intra-Cellular Therapies Inc.

About

Profile


Headquarters

United States of America


Intraday

High
-
Low
-

52-week

High
-
Low
-

ITCI

The stock soared nearly 34% after Johnson & Johnson announced it will take over the neurological treatment company for $132 per share. That values Intra-Cellular Therapies at $14.6 billion. Shares of Johnson & Johnson were flat.


 
...

Available for logged in users only.



The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.
  • Intra-Cellular Therapies GAAP EPS of -$0.30 beats by $0.15, revenue of $132M misses by $3.67M
  • Intra-Cellular Therapies Q4 2023 Earnings Preview
  • Bank of America more favorable on SMID-cap biotechs into 2024
  • Bristol-Karuna deal: What other biotechs might be in M&A crosshairs?
  • Intra-Cellular Therapies gains amid repeated takeover speculation
  • Intra-Cellular Therapies GAAP EPS of -$0.25 beats by $0.34, revenue of $126.17M beats by $6.94M
  • Intra-Cellular Therapies Q3 2023 Earnings Preview
  • Intra-Cellular Therapies beats top and bottom line estimates, gives FY guidance
  • Intra-Cellular Therapies Q2 2023 Earnings Preview
  • Intra-Cellular Therapies GAAP EPS of -$0.46 beats by $0.16, revenue of $95.31M beats by $2.9M
  • Intra-Cellular Therapies Q1 2023 Earnings Preview
  • Morgan Stanley's Wilson screens for stocks as earnings stabilize but data disappoints
  • What is behind biotech M&A resurgence?
  • Morgan Stanley starts Intra-Cellular at Overweight on schizophrenia therapy
  • Alnylam, Intra-Cellular among potential biotech take-out targets - RBC
  • Intra-Cellular jumps 14% after early data for depression candidate
  • Intra-Cellular Therapies GAAP EPS of -$0.45 beats by $0.15, revenue of $87.87M beats by $0.9M
  • Intra-Cellular Therapies Q4 2022 Earnings Preview
  • Intra-Cellular stock surges 11% as bipolar depression drug sales skyrockets in Q3
  • Intra-Cellular Therapies GAAP EPS of -$0.57 beats by $0.25, revenue of $71.9M beats by $5.9M
Date Price Open High Low Vol Change
Jan 29 127.02 127.38
127.38
126.94
2.4M 0.02%
Jan 28 127 127.16
127.25
126.94
2.1M -0.17%
Jan 27 127.21 127.31
127.46
127.15
2.7M -0.11%
Jan 24 127.35 127.2
127.61
127.18
4.1M 0.22%
Jan 23 127.07 127.19
127.43
127.07
4.9M -0.06%
 
Jan 22 127.15 127
127.6
127
6.3M 0.51%
Jan 21 126.5 126.64
126.93
126.43
6.4M 0.24%
Jan 17 126.2 126.65
126.74
126.16
6.0M -0.05%
Jan 16 126.26 127
127.09
126.25
7.5M -0.36%
Jan 15 126.71 126.91
127.16
126
7.7M -0.14%
Jan 14 126.89 127.19
127.45
126.75
16.6M -0.24%
Jan 13 127.19 127.95
128
126.9
35.9M 34.07%
Jan 10 94.87 86.53
98.39
86.25
4.1M 14.91%
Jan 8 82.56 83
83.05
81.86
418K -0.8%
Jan 7 83.23 81.68
84.19
80.82
722K 1.77%
Jan 6 81.78 83.71
83.75
81.4
697K -2.32%
Jan 3 83.72 84.59
84.64
82.76
368K -0.62%
Jan 2 84.24 84.16
84.99
83.75
510K 0.86%
Dec 31, 2024 83.52 83.67
84.7
83.05
345K 0.05%
Dec 30, 2024 83.48 84.21
84.86
82.32
425K -1.61%
Dec 27, 2024 84.85 85.62
86.25
84.14
485K -1.34%
Dec 26, 2024 86 84.6
86.36
84.4
278K 0.89%
Dec 24, 2024 85.24 83.93
85.78
83.46
187K 1.48%
Dec 23, 2024 84 83.86
84.52
83.06
345K 0.66%
Dec 20, 2024 83.45 84.54
85.03
82.76
1.1M -0.82%
Dec 19, 2024 84.14 86.59
87.95
83.42
711K -2.98%
Dec 18, 2024 86.72 87.86
89.12
86.09
1.1M -0.28%
Dec 17, 2024 86.96 84.94
87.07
84.15
538K 2.17%
Dec 16, 2024 85.11 82.55
85.5
82.19
454K 2.51%
Dec 13, 2024 83.03 83.12
83.91
82.14
367K -0.44%
Dec 12, 2024 83.4 83.96
84.31
82.61
395K -0.57%
Dec 11, 2024 83.88 83.42
84.18
81.37
434K 0.93%
Dec 10, 2024 83.11 85.23
85.58
82.89
319K -2.18%
Dec 9, 2024 84.96 84.15
85.44
82.84
481K 0.48%
Dec 6, 2024 84.55 84
84.71
83.39
275K 0.55%
Dec 5, 2024 84.09 85.41
85.41
83.52
375K -2.16%
Dec 4, 2024 85.95 85
86.32
84.73
427K 0.75%
Dec 3, 2024 85.31 86.01
86.76
84.47
346K -0.84%
Dec 2, 2024 86.03 85.53
86.99
85.39
467K 0.44%
Nov 29, 2024 85.65 86.19
86.59
84.63
276K -1.09%
Nov 27, 2024 86.59 85.57
86.78
85.13
403K 0.19%
Nov 26, 2024 86.43 85.32
86.6
84.72
294K 1.69%
Nov 25, 2024 84.99 86.27
86.86
84.89
465K -0.82%
Nov 22, 2024 85.69 85.88
86.1
84.74
438K 0.28%
Nov 21, 2024 85.45 85.51
86.05
84.38
390K -0.22%
Nov 20, 2024 85.64 83.35
86.36
82.77
408K 2.75%
Nov 19, 2024 83.35 82.64
83.49
81.9
704K 1.07%
Nov 18, 2024 82.47 83.56
83.61
81.83
585K -1.14%
Nov 15, 2024 83.42 86.77
87.12
83.21
628K -4.8%
Nov 14, 2024 87.63 88
89.33
87.4
616K -0.67%
Nov 13, 2024 88.22 88.49
89.62
87.52
982K -0.31%
Nov 12, 2024 88.49 91
91.52
88.18
792K -3.36%
Nov 11, 2024 91.57 91.73
93.45
90.63
922K 0.31%
Nov 8, 2024 91.29 89.57
91.4
89.28
586K 0.86%
Nov 7, 2024 90.51 89.86
91.68
89.41
587K 1.20%
Nov 6, 2024 89.44 90
90.25
87.48
698K 0.22%
Nov 5, 2024 89.24 85.79
89.44
85.08
507K 3.56%
Nov 4, 2024 86.17 86.41
87.31
86.02
713K -0.43%
Nov 1, 2024 86.54 84.84
86.98
84.36
935K 2.11%
Oct 31, 2024 84.75 85.01
86.88
84.57
1.1M 0%